UpdatesGeneral Updates
Emcure's Sanand facility received a US FDA Form 483 with 7 procedural observations following an inspection.
Emcure Pharmaceuticals LimitedEMCURE · Filed with the exchange
The company is addressing these findings and plans to respond to the FDA promptly, highlighting ongoing operational compliance efforts.
No comments yet. Be the first.